MyCEI Login


Prostate Cancer in Cisgender Gay and Bisexual Men and Trans Women


Published Date: 05/23/2022

Expiration Date: 04/19/2025

CE Credit: CME:1


Channa A. Amarasekera,MD

Channa A. Amarasekera, MD is an Assistant Professor of Urology at Northwestern University Feinberg School of Medicine with a clinical focus on men’s health, sexual medicine, and reconstructive surgery. He has a special interest in Peyronie’s disease, erectile dysfunction, and prostate cancer survivorship. His research is dedicated to identifying and addressing urologic healthcare disparities faced by sexual minorities. He graduated summa cum laude from the University of Maryland with a degree in Cell Biology and Molecular Genetics and attended Harvard Medical School. He did his residency training at Northwestern. Dr. Amarasekera is the director of the Gay and Bisexual Men’s Urology Program-the nation’s first urology clinic targeting the needs of gay and bisexual men. With Dr. Amarasekera`s leadership, this patient-centered program is designed to improve the urologic care experience, outcomes and quality of life for patients who were assigned male at birth (AMAB) and identify as gay or bisexual.

Learning Objectives

  • Learn about the current clinical terminology used to identify sexual minority patients.
  • Know the unique impacts of prostate cancer on cisgender gay and bisexual men and trans women.
  • Understand how HIV infection influences prostate cancer screening and treatment.

Continuing Education Credit Information